Winton Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
$84.6M Buy
2,775,073
+721,983
+35% +$21.5M 0.58% 19
2013
Q4
$59.7M Buy
2,053,090
+279,382
+16% +$8.13M 0.54% 27
2013
Q3
$48.3M Buy
1,773,708
+160,070
+10% +$4.36M 0.58% 25
2013
Q2
$42.9M Buy
+1,613,638
New +$44.6M 0.52% 48

Other funds holding PFE

Winton Capital Management's PFE Position: Q1 2014 in Review

Winton Capital Management increased its Pfizer (PFE) stake by 35% in Q1 2014, buying an estimated $21.5M and bringing the position to 2,775,073 shares worth $84.6M. The position accounts for 0.58% of the portfolio, ranked #19.

Winton Capital Management first reported a position in PFE in Q2 2013 and has held it in 4 quarters since. 1,781 funds tracked by Wall St. Rank hold PFE as of Q1 2014.

  • Winton Capital Management held 2,775,073 shares of Pfizer worth $84.6M as of Q1 2014.
  • Winton Capital Management bought 721,983 Pfizer shares in Q1 2014, an estimated $21.5M.
  • Pfizer made up 0.58% of Winton Capital Management's portfolio in Q1 2014, its #19 holding.
  • Winton Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 4 quarters since.
  • 1,781 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.